Audion Therapeutics

Audion Therapeutics was founded in 2009 by Rolf Jan Rutten, with the mission to discover, develop and commercialize new drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss.

Audion Therapeutics is one of the participants of the REGAIN project — the EU funded project under the Horizon 2020 programme, with the aim to develop and test a new drug to treat hearing loss caused by the loss of sensory hair cells in the inner ear.

Clinical trials to be announced.

RECENT NEWS ON AUDION THERAPEUTICS

Nothing Found

Sorry, no posts matched your criteria

COMPANY OVERVIEW

Audion Therapeutics

Locations: Netherlands
Year Founded: 2009
CEO: Rolf Jan Rutten